{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:50:49Z","timestamp":1790985049717,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Testicular germ cell tumors (TGCTs) are malignant neoplasms with a poor prognosis, and the absence of reliable biomarkers for patient stratification and diagnosis presents a significant challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed an integrated analysis of Single-Cell RNA-Sequencing and TCGA data to evaluate TNFSF10 as a potential biomarker for prognosis and immunotherapy in TGCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings revealed that aberrant TNFSF10 expression was significantly associated with patient survival outcomes. Silencing TNFSF10 inhibited the proliferation, migration, and invasion of TGCT cells, highlighting its role in tumor progression. Moreover, TNFSF10 expression was closely correlated with various components of the tumor microenvironment, suggesting its involvement in both the biological behavior of TGCTs and their response to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TNFSF10 emerges as a promising diagnostic and prognostic biomarker for stratification and targeted therapy in TGCTs, offering new prospects for personalized treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1761075","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:27Z","timestamp":1777354647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["TNFSF10: a promising prognostic biomarker and therapeutic target for immunotherapy in testicular germ cell tumors"],"prefix":"10.3389","volume":"17","author":[{"given":"Guangmin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pathology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University\/Hunan Cancer Hospital","place":["Changsha, China"]},{"name":"National Health Commission Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Central South University","place":["Changsha, China"]},{"name":"Department of Laboratory Medicine, Dongying People\u2019s Hospital","place":["Dongying, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Du","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Lv","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University\/Hunan Cancer Hospital","place":["Changsha, China"]},{"name":"National Health Commission Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Urology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University\/Hunan Cancer Hospital","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Fan","sequence":"additional","affiliation":[{"name":"National Health Commission Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Central South University","place":["Changsha, China"]},{"name":"Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Hospital of Changsha, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongrong","family":"Xu","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University\/Hunan Cancer Hospital","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01231-1","article-title":"Emerging role of biomarkers in testicular germ cell tumors","volume":"24","author":"Soleimani","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.10.023","article-title":"Epidemiology and risk factors for testicular cancer: a systematic review","volume":"87","author":"Tateo","year":"2024","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2010.196","article-title":"Testicular germ cell tumors: pathogenesis, diagnosis and treatment","volume":"7","author":"Winter","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0029-0","article-title":"Testicular cancer","volume":"4","author":"Cheng","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00991-5","article-title":"Testicular germ cell tumours","volume":"387","author":"Rajpert-De Meyts","year":"2016","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1096494","article-title":"Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: gene expression, mutation and alternative splicing","volume":"13","author":"Yao","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00440-w","article-title":"Late adverse effects and quality of life in survivors of testicular germ cell tumour","volume":"18","author":"Chovanec","year":"2021","journal-title":"Nat Rev Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.871489","article-title":"Single-cell RNA sequencing of metastatic testicular seminoma reveals the cellular and molecular characteristics of metastatic cell lineage","volume":"12","author":"Mo","year":"2022","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.10.026","article-title":"TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease","volume":"107","author":"Lv","year":"2024","journal-title":"Kidney Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"00054-8","DOI":"10.1016\/j.jare.2026.01.029","article-title":"TNFSF10 drives hyperactive immune responses via NLRP3 inflammasome and endoplasmic reticulum stress in autoimmune and inflammatory diseases","author":"Zhang","year":"2026","journal-title":"J Adv Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040499","article-title":"Regulation of cancer metastasis by TRAIL\/death receptor signaling","volume":"11","author":"Oh","year":"2021","journal-title":"Biomolecules"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.004","article-title":"Insight into the role of TRAIL in liver diseases","volume":"110","author":"Jiang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147628","article-title":"Enhancing the effect of tumor necrosis factor-related apoptosis-inducing ligand signaling and arginine deprivation in melanoma","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","author":"Becht","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-023-00844-y","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J Big Data"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2022.06.046","article-title":"Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment","volume":"20","author":"Wang","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14654","article-title":"Testis developmental related gene 1 regulates the chemosensitivity of seminoma TCam-2 cells to cisplatin via autophagy","volume":"23","author":"Peng","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2016.1178425","article-title":"TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K\/Akt\/mTOR signaling pathway and mitochondria-mediated apoptotic pathway","volume":"17","author":"Gan","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0099-2","article-title":"The adult human testis transcriptional cell atlas","volume":"28","author":"Guo","year":"2018","journal-title":"Cell Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41420-021-00588-9","article-title":"Integrated analysis of high-throughput sequencing data reveals the key role of LINC00467 in the invasion and metastasis of testicular germ cell tumors","volume":"7","author":"Bo","year":"2021","journal-title":"Cell Death Discov"},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"16","author":"Steeg","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","article-title":"Targeting the microenvironment in solid tumors","volume":"65","author":"Belli","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31357","article-title":"IFN-\u03b3-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddac168","article-title":"An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer","volume":"32","author":"Han","year":"2023","journal-title":"Hum Mol Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13046-021-01972-0","article-title":"TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas","volume":"40","author":"Zhang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12656","article-title":"Immune mechanisms and possible immune therapy in testicular germ cell tumours","volume":"7","author":"Chovanec","year":"2019","journal-title":"Andrology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118610","article-title":"Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: potential treatment options against testicular germ cell tumors","volume":"14","author":"Schepisi","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1761075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:28Z","timestamp":1777354648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1761075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1761075"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1761075","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1761075"}}